{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:45:18Z","timestamp":1761871518072,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.clml.2021.04.016","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T08:03:37Z","timestamp":1622448217000},"page":"606-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic"],"prefix":"10.1016","volume":"21","author":[{"given":"Martin","family":"\u010cer\u0148an","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1\u0161","family":"Szotkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ale\u0161","family":"Obr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vojt\u011bch","family":"L\u00e1tal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton\u00edn","family":"Hlu\u0161\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Krhovsk\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Klementov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Kol\u00e1\u0159","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Faber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1\u0161","family":"F\u00fcrst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1\u0161","family":"Papaj\u00edk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2021.04.016_bib0001","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.clml.2021.04.016_bib0002","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000508199","article-title":"Treating leukemia in the time of COVID-19","volume":"144","author":"Shilpa","year":"2021","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clml.2021.04.016_bib0003","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1016\/j.clon.2020.10.021","article-title":"Estimating the risk of death from COVID-19 in adult cancer patients","volume":"33","author":"Williams","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clml.2021.04.016_bib0004","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1182\/blood.2020008824","article-title":"Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients","volume":"136","author":"Vijenthira","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.04.016_bib0005","article-title":"Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies","volume":"87","author":"Borah","year":"2020","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.clml.2021.04.016_bib0006","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1111\/ijlh.13301","article-title":"COVID-19 in patients with hematological malignancies: a retrospective case series","volume":"42","author":"Infante","year":"2020","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.clml.2021.04.016_bib0007","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13045-020-00970-7","article-title":"Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study","volume":"13","author":"Garc\u00eda-Su\u00e1rez","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.clml.2021.04.016_bib0008","unstructured":"Coronavirus disease 2019 (COVID-19): Management in hospitalized adults. Uptodate.com. Available at: https:\/\/www.uptodate.com\/contents\/coronavirus-disease-2019-covid-19-management-in-hospitalized-adults; 2021. Accessed January 21, 2021."},{"key":"10.1016\/j.clml.2021.04.016_bib0009","unstructured":"Clinical management of COVID-19. Who.int. https:\/\/www.who.int\/publications\/i\/item\/clinical-management-of-covid-19; 2021. Accessed January 21, 2021."},{"year":"2020","series-title":"L\u00e9\u010debn\u00e9 Postupy v Hematologii [in Czech]","key":"10.1016\/j.clml.2021.04.016_bib0010"},{"key":"10.1016\/j.clml.2021.04.016_bib0011","unstructured":"Epidemiology of covid-19 infection in patients with hematological malignancies: A European Haematology Association survey. Seifem.org. https:\/\/seifem.org\/wp-content\/uploads\/2020\/11\/1-EPICOVIDEHA-synopsis-LIVIO-PAGANO.pdf; 2021. Accessed February 12, 2021."},{"key":"10.1016\/j.clml.2021.04.016_bib0012","unstructured":"iCMLf - COVID-19 case collection and case discussion. CML-foundation.org. https:\/\/www.cml-foundation.org\/covid-19-hub\/1462-the-international-cml-foundation-and-covid-19-covid-19-case-collection-2.html; 2021. Accessed February 12, 2021."},{"key":"10.1016\/j.clml.2021.04.016_bib0013","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1159\/000510769","article-title":"COVID-19 in patients with hematologic disorders undergoing therapy: perspective of a large referral hematology center in Rome","volume":"143","author":"Girmenia","year":"2020","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clml.2021.04.016_bib0014","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1111\/bjh.16758","article-title":"Ph+ acute lymphoblastic leukaemia in Italy during the Covid-19 pandemic: a Campus ALL study","volume":"190","author":"Fo\u00e0","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2021.04.016_bib0015","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1038\/s41375-020-0904-z","article-title":"Campus CML working group. Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey","volume":"34","author":"Breccia","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.04.016_bib0016","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/s41375-020-0853-6","article-title":"COVID-19 in persons with chronic myeloid leukaemia","volume":"34","author":"Li","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.04.016_bib0017","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jmv.26404","article-title":"The outcome of COVID-19 in patients with hematological malignancy","volume":"93","author":"Yigenoglu","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.clml.2021.04.016_bib0018","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood.2020006288","article-title":"The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19\u2013infected patients","volume":"135","author":"Treon","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.04.016_bib0019","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s43018-020-00122-3","article-title":"The immuno-oncological challenge of COVID-19","volume":"1","author":"Derosa","year":"2020","journal-title":"Nature Cancer"},{"key":"10.1016\/j.clml.2021.04.016_bib0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2021.04.016_bib0021","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/CM9.0000000000000824","article-title":"Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study","volume":"133","author":"Deng","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.clml.2021.04.016_bib0022","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cca.2020.06.013","article-title":"C-reactive protein: a promising biomarker for poor prognosis in COVID-19 infection","volume":"509","author":"Sahu","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clml.2021.04.016_bib0023","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejca.2020.08.017","article-title":"High mortality among hospital-acquired COVID-19 infection in patients with cancer: a multicentre observational cohort study","volume":"139","author":"Elkrief","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clml.2021.04.016_bib0024","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1111\/bjh.16935","article-title":"Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience","volume":"190","author":"Shah","year":"2020","journal-title":"Br J Haematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021001762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021001762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:35:51Z","timestamp":1761870951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265021001762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2152265021001762"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2021.04.016","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2021.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}